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Background: Early seizure (ES) may complicate the clinical course of patients with acute stroke. 
The aim of this study was to assess the rate of and the predictive factors for ES as well the effects 
of ES on the clinical outcome at hospital discharge in patients with ﬁ  rst-ever stroke.
Patients and methods: A total of 638 consecutive patients with ﬁ  rst-ever stroke (543 isch-
emic, 95 hemorrhagic), admitted to our Stroke Unit, were included in this prospective study. 
ES were deﬁ  ned as seizures occurring within 7 days from acute stroke. Patients with history 
of epilepsy were excluded.
Results: Thirty-one patients (4.8%) had ES. Seizures were signiﬁ  cantly more common in patients 
with cortical involvement, severe and large stroke, and in patient with cortical hemorrhagic 
transformation of ischemic stroke. ES was not associated with an increase in adverse outcome 
(mortality and disability). After multivariate analysis, hemorrhagic transformation resulted as 
an independent predictive factor for ES (OR = 6.5; 95% CI: 1.95–22.61; p = 0.003).
Conclusion: ES occur in about 5% of patients with acute stroke. In these patients hemorrhagic 
transformation is a predictive factor for ES. ES does not seem to be associated with an adverse 
outcome at hospital discharge after acute stroke.
Keywords: seizures, stroke, cortical involvement, hemorrhagic transformation
Introduction
Complications occurring during the early phase after an acute stroke are major deter-
minants of the ﬁ  nal outcome of this serious vascular event (Davenport et al 1996). 
Understanding the nature and timing of these complications is crucial for an appropriate 
management of patients with acute stroke.
Stroke is the most common cause of acute symptomatic seizures in the elderly 
population (Forsgren et al 1996). Although, there are different timing-based deﬁ  ni-
tions of stroke-associated ES, most authors identify early seizures as those occurring 
within 7–14 days after acute stroke onset (Bladin et al 2000; Labovitz et al 2001; 
Lamy et al 2003; Ferro and Pinto 2004). Seizures occurring after this time window 
are deﬁ  ned as late seizures. This distinction underlies possible differences concerning 
the pathophysiology of and risk factors for early and late seizures.
Symptomatic seizures have been reported to occur in 2 to 33% of patients with 
acute stroke (Gupta et al 1988; Kilpatrick et al 1992; Giroud et al 1994; Ryvlin et al 
2006). The reported wide range of percentages is probably explained by the analysis 
of retrospective studies, different window for deﬁ  ning ES (range 1–30 days) and the 
inclusion in the analysis of patients with different types of stroke. Several studies have 
tried to identify the predictive factors for ES after acute ischemic and hemorrhagic 
stroke with controversial results. Stroke severity, hemorrhagic stroke, and cortical 
involvement were the predictive factors more often reported (So et al 1996; Arboix et al 
1997; Reith et al 1997; Bladin et al 2000; Labovitz et al 2001; Lamy et al 2003).Vascular Health and Risk Management 2008:4(3) 716
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The aim of this study was to determine the rate of and the 
predictive factors for ES as well as the inﬂ  uence of ES on the 
clinical outcome in patients with ﬁ  rst-ever acute stroke.
Patients and methods
Patients with acute ischemic or hemorrhagic ﬁ  rst-ever 
stroke admitted to the Stroke Unit at the Department of Cardio-
vascular Medicine, University of Perugia, from October 2004 
to May 2007 were prospectively and consecutively included 
in this study. Patients with transient ischemic attack (TIA), 
subarachnoid hemorrhage, and cerebral vein thrombosis were 
excluded from the study as were patients with a history of 
epilepsy. All patients were assessed by the study neurologist to 
conﬁ  rm the diagnosis and the aetiological subtypes of stroke 
(Adams et al 1993). Stroke was deﬁ  ned according to the World 
Health Organization’s criteria, that is, sudden onset of signs of 
focal or global disturbance of cerebral function lasting more 
than 24 hours with no apparent nonvascular cause (WHO 
1989). All patients underwent brain computed tomography 
(CT) scan on admission, which was repeated 3–7 days from 
stroke onset. Cerebral magnetic resonance imaging (MRI) 
was performed on selected patients (eg, in those with a second 
negative CT scan (10%)). Overall, 15% of patients were studied 
by MRI with diffusion weighted imaging. Ischemic stroke was 
classiﬁ  ed as cortical and subcortical based on neuroimaging. 
The size of ischemic infarcts was classiﬁ  ed as small if lesion 
1.5 cm; medium if lesion was in a cortical superﬁ  cial branch 
of middle cerebral artery (MCA), or lesion involving the 
MCA deep branch, or lesion internal border zone territories, 
or lesion in a cortical superﬁ  cial branch of posterior cerebral 
artery (PCA), or lesion involving the PCA branch or lesion in 
a cortical superﬁ  cial branch of anterior cerebral artery (ACA); 
large if the lesion involving whole territory of ACM, ACP or 
ACA, or the lesion involving two cortical superﬁ  cial branches 
of MCA, or the lesion involving a cortical superﬁ  cial branch of 
MCA associated to the MCA deep branch, or the lesion involv-
ing more than 1 artery territory and lesion involving brainstem 
or cerebellum 1.5 cm. In patients with hemorrhagic stroke 
the size was considered large if the maximal diameter of the 
lesion was 3 cm. Clinical outcome measured including 
mortality and disability at discharge, according to modiﬁ  ed 
Rankin score: 0,1,2: non-disabling stroke; 3,4,5 : disabling 
stroke (De Haan et al 1995).
ES was deﬁ  ned as seizure occurring within 7 days from 
stroke onset, according to the International League Against 
Epilepsy guidelines (1993). Transient change in the level of 
consciousness or amnesia were not considered for a diagnosis 
of epileptic seizure.
Data on patient vascular risk factors were collected 
which included: age, gender, hypertension (blood pressure 
140/90 at least twice before stroke under treatment with 
antihypertensive drugs), diabetes mellitus (glucose levels 
126 mg dL preprandial on two examinations, glucose 
level 200 mg dL postprandial, or HbA1c 8.5%), current 
cigarette smoking, hyperlipidemia (cholesterol concentration 
of 200 mg dL and /or triglyceride concentration 140 mg 
dL on admission or already under statins), history of ischemic 
heart disease, atrial ﬁ  brillation, intermittent claudication, or 
previous transient ischemic attacks.
Four hundred and thirty-six consecutive patients enrolled 
over the ﬁ  nal 18 months of the study were also examined for 
stroke severity on admission and the occurrence presence of 
hemorrhagic transformation (HT). Stroke severity was evalu-
ated at admission using the National Institute of Health Stroke 
Scale (NIHSS). HT, deﬁ  ned as any degree of hyperdensity 
within the area of low attenuation, was evaluated in patients 
with ischemic stroke on admission by TC which was repeated 
7 days later. In these patients the association between HT and 
antithrombotic therapy was also examined.
ES predictors were assessed by univariate analysis and 
multiple logistic regression analysis. In the univariate analy-
sis, comparing each of the categorical baseline variables in 
patients with ES with those in patients without ES, χ2-test 
or Fisher’s exact test were used when appropriate. Statistical 
signiﬁ  cance was set at p  0.05. For the multiple logistic 
regression analysis, the independent variables were selected 
from the univariate analysis using backward stepwise analysis 
with a level of 0.1 as a screening criterion for selection of 
candidate variables.
The next step of analysis was aimed at identifying pre-
dictors of severe outcome. In the univariate analysis each of 
the baseline variables including ES of the group of patients 
alive/non disabled was compared to that group of patients 
dead/disabled using χ2 test or Fisher’s exact test when appro-
priate. Statistical signiﬁ  cance was set at 0.05. Multiple 
logistic regression analysis was used to identify independent 
predictors of adverse outcome.
All analyses were performed with the SPSS/PC Win 
package 13.0 (SPSS Inc., Chicago, IL, USA).
Results
A total of 638 patients (mean age 72.8 ± 13.2 years) with a 
ﬁ  rst-ever acute stroke were included in the study. Of them, 
543 suffered an ischemic stroke (85.1%) and 95 had a hem-
orrhagic stroke (14.9%). ES were diagnosed in 31 patients 
(4.8%). Twenty-one of the patients with ES (67%) were Vascular Health and Risk Management 2008:4(3) 717
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males. The clinical features of patients with and without 
seizure are reported in Table 1. No statistically signiﬁ  cant 
difference concerning age, gender and risk factors for stroke 
were seen between patients with and without seizures. No 
difference was found in the rate of ES between ischemic 
and hemorrhagic strokes. In the univariate analysis cortical 
involvement was more frequent in patients with ES than 
in patients without ES (58% vs 33%). Furthermore, stroke 
lesion was larger in patients with ES than in patients without 
ES (29% vs 15%).
Globally, 436 consecutive patients (mean age: 72.8 ± 13.0; 
368 ischemic stroke) were evaluated for stroke severity on 
admission and the presence of HT. In these patients, the 
univariate analysis showed that the initial stroke severity on 
admission was signiﬁ  cantly higher in patients with ES than 
in patients without ES (means NIHSS: 13.2 ± 9.3 vs 10.0 ± 
7.3; p = 0.05). HT was more common in patients with ES 
than in patients without ES (36.8% vs 7.7%; p = 0.001) 
(Table 2). In the patient group with ES, HT was cortical in 
83.7% of the cases (6/7). After multivariate analysis, HT 
(OR = 6.58; 95% CI: 1.95–22.61; p = 0.003) resulted as an 
independent factor for developing seizures in patient with ﬁ  rst 
ever stroke, while the NIHSS (OR: 1.47; 95% CI: 1.34–1.61; 
p = 0.001) and HT (OR: 8.45; 95% CI: 1.73–41.20; p = 0.008) 
were independently associated with adverse outcome. 41 
patients had been taking anticoagulant and 161 patients 
had antiplatelet therapy before stroke onset. HT occurred in 
6/41 (14.6%) and 15/161 (9.3%). No relation was observed 
between antithrombotic therapy and HT (p = 0.1 and p = 0.3 
respectively).
At discharge, 348 patients were dead (66, 10.3%) or dis-
abled (282, 44.2%) (Table 3). ES did not inﬂ  uence hospital 
mortality/disability (OR: 0.92; 95% CI: 0.31–2.73). Hemor-
rhagic stroke (OR: 7.24; 95% CI: 2.3–21.9; p = 0.001) and 
large lesion size (OR: 19.47; 95% CI: 5.86–6.46; p = 0.001) 
resulted being the most important predictive factors for 
disability.
Discussion
In this study, ES occurred in 4.8% of patients with ischemic 
or hemorrhagic stroke. The main ﬁ  ndings of this study 
were that ES were more common in patients with cortical 
lesion than in those without cortical involvement and that 
ES were not associated with an adverse outcome at hospital 
discharge.
The reported rate of ES in our study was within the 
range (2% to 6%) of those reported in prospective studies 
in which ES were deﬁ  ned as those occurring within 7 days 
from of acute stroke onset (So El et al 1996; Labovitz et al 
2001; Lamy et al 2003). No differences between age and 
gender were found between patients with and without ES. 
These data are consistent with those reported in previous 
studies (Reith et al 1997; Labovitz et al 2001), although age 
younger than 65 years and male gender have been shown to 
Table 1 Main features of patients with and without ES
  Total n (%)  With ES n (%)  Without ES n (%)  Univariate analysis
         p
No. of patients  638  31(4.8)  607 
Mean age  72.8 ± 13.2  76.8 ± 10.3  72.6 ± 13.3 
Sex, male  364 (57)  21 (67)  343 (56.5) 
Risk factors       
Hypertension  450 (70.6)  26 (83.8)  424 (69.9) 
Diabetes  138 (21.6)  6 (19.3)  132 (21.2) 
Ischemic heart disease  112 (7.5)  6 (19.3)  106 (17.4) 
Atrial ﬁ  brillation  139 (21.8)  5 (16.1)  134 (22.2) 
Peripheral arterial disease  27 (4.2)  2 (6.4)  25 (4.1) 
Hyperlipidemia  240 (37.6)  11 (35.4)  229 (37.7) 
Smoking  155 (24.2)  10 (31.2)  145 (23.9) 
Previous TIA  30 (4.7)  1 (3.2)  29 (4.7) 
Clinical data       
Hemorrhagic stroke  95 (14.9)  5 (16.3)  90 (14.8) 
Lacunar  128 (20.0)  4 (12.9)  124 (20.5) 
Atherothrombotic  144 (22.5)  9 (29.0)  135 (22.2) 
Cardioembolic  150 (23.5)  7 (22.5)  143 (23.5) 
Cortical involvement  230 (36.0)  18 (58.1)  212 (33.2)  0.01
Large size  97 (15.2)  9 (29.0)  88 (14.8)  0.03Vascular Health and Risk Management 2008:4(3) 718
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Table 2 Comparison of patients with and without ES evaluated for NIHSS and HT
  Total n (%)  With ES n (%)  Without ES n (%)  Univariate analysis
       p 
No. of patients  436  22 (5.0)  414 
Mean age  72.8 ± 13.0  75.9 ± 11.4  72.6 ± 13.1 
Sex, male  251 (57.5)  16 (72.7)  235 (56.8) 
Risk factors       
Hypertension  321 (73.6)  19 (86.4)  302 (72.9) 
Diabetes  95 (21.8)  6 (27.2)  89 (21.5) 
Ischemic heart disease  57 (13.1)  2 (9.1)  55 (13.3) 
Atrial ﬁ  brillation  105 (24.1)  4 (18.1)  101 (24.3) 
Peripheral arterial disease  16 (3.7)  2 (9.1)  14 (3.4) 
Hyperlipidemia  171 (39.2)  10 (45.4)  161 (38.9) 
Smoking  129 (29.6)  10 (45.4)  119 (28.7) 
Previous TIA  22 (5.0)  1 (4.5)  21 (5.1) 
Clinical data       
Ischemic stroke  368 (84.4)  19 (86.3)  349 (84.2) 
Lacunar  100 (22.9)  4 (18.1)  96 (23.1) 
Atherothrombotic  95 (21.8)  7 (31.8)  88 (21.2) 
Cardioembolic  105 (24.1)  4 (18.1)  101 (24.4) 
Cortical involvement  168 (38.5)  14 (63.6)  154 (37.1)  0.01
Large size  65 (14.9)  6 (27.3)  59 (14.2)  0.008
Hemorrhagic transformation  34 (9.2)  7 (36.8)  27 (7.7)  0.001
NIHSS (score)  10.1 ± 7.5  13.2 ± 9.3  10.0 ± 7.3  0.05
Table 3 Patient characteristics and outcome
 Total  n  (%)  Rankin  3 n (%)  Rankin 3 n (%)  Univariate analysis
       p 
No. of patients  638  290  348 
Mean age  72.8 ± 13.2  67.8 ± 13.1  76.9 ± 11.5  0.001
Sex, male  363 (56.9)  190 (65.5)  173 (49.7)  0.001
Risk factors       
Hypertension  450 (70.5)  192 (66.2)  258 (74.1)  0.04
Diabetes  136 (21.3)  60 (20.6)  76 (21.8) 
Ischemic heart disease  110 (17.2)  48 (16.5)  62 (17.8) 
Atrial ﬁ  brillation  138 (22.0)  39 (13.7)  99 (28.9)  0.001
Peripheral arterial disease  25 (3.9)  8 (2.7)  17 (4.9) 
Hyperlipidemia  244 (38.2)  122 (42.0)  122 (35.0)  0.057
Smoking  155 (24.2)  78 (26.8)  77 (22.1) 
Previous TIA  30 (4.7)  12 (4.1)  18 (5.2) 
Clinical data       
With ES  31 (4.8)  13 (4.5)  18 (5.2) 
Hemorrhagic stroke  95 (14.9)  25 (26.3)  70 (73.7)  0.001
Lacunar  133 (20.8)  72 (24.8)  61 (17.5)  0.03
Atherothrombotic  149 (23.3)  66 (22.7)  83 (23.8) 
Cardioembolic  152 (23.8)  46 (15.9)  106 (30.4)  0.001
Cortical involvement  242 (37.9)  83 (28.6)  159 (45.6)  0.001
Large size  106 (16.6)  15 (5.2)  91 (26.1)  0.001
NIHSS (score)  436/638  5.0 ± 3.3  14.2 ± 7.3  0.0001
Hemorrhagic transformation  34 (9.2)  5 (2.9)  29 (14.9)  0.0001Vascular Health and Risk Management 2008:4(3) 719
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be a risk factors for ES in some other reports (Olsen et al 
1987; Misirli et al 2006).
Consistently with the most recent studies (Labovitz et al 
2001; Lamy et al 2003), hypertension, diabetes mellitus, 
smoking, hyperlipidemia, ischemic heart disease, atrial ﬁ  bril-
lation or previous TIA were not associated with ES.
We did not ﬁ  nd a signiﬁ  cant correlation between seizure 
and hemorrhagic stroke such as providing negative data to 
the controversial debate related the increased rate of ES in 
patients with hemorrhagic stroke (Lo et al 1994; Arboix 
et al 1997; Reith et al 1997; Berges et al 2000; Bladin et al 
2000; Labovitz et al 2001). We did not observe an association 
between stroke etiology, particularly cardioembolic stroke, 
and the occurrence of ES. This is of interest as cardioem-
bolic infarction has been a controversial risk factor for ES 
for years (Lesser et al 1985; Kittner et al 1990; Giroud et al 
1994; Kraus et al 1998; Bladin et al 2000; Misirli et al 2006; 
So et al 2006).
Our study showed that ES was signiﬁ  cantly more frequent 
in stroke patients with cortical lesions than in those patients 
without cortical involvement such conﬁ  rming the results of 
most previous studies (Kilpaptrik et al 1992; Lo et al 1994; 
Arboix et al 1997; Labovitz et al 2001; Lamy et al 2003), but 
not the results of some others (Gupta et al 1988; Shinton et al 
1988). Early seizures after stroke onset are probably the clini-
cal mirror of cortical brain damage. Cortical irritation can 
increase the excitability and lead to the onset of seizure.
The clinical relevance of the cortical involvement in the 
development of ES has been conﬁ  rmed by a prospective study 
based on EEG in acute stroke patients. This study found a 
relationship between electrical epileptic activity and cortical 
lesion (Carrera et al 2006). In our study, after multivariate 
analysis, the cortical involvement was not signiﬁ  cant for ES 
(OR: 2.54; 95% CI: 0.85–7.55; p = 0.09), although a trend 
was observed.
Lesion size (Gupta et al 1988), and especially stroke 
severity, were reported to be related to ES. The prospective 
Copenhagen study (Reith et al 1997) of ischemic stroke 
patients showed that initial stroke severity measured with the 
Scandinavian Stroke Scale was the only factor related to ES, 
and initial stroke severity assessed by NIHSS at admission, 
was found to be an independent predictor of electrical epi-
leptic activity (Carrera et al 2006). Another prospective mul-
ticenter study reported that stroke severity was independently 
associated with seizure after acute ischemic stroke (Bladin 
et al 2000), while another study did not conﬁ  rm these data 
(Labovitz et al 2001). Also our data demonstrated that large 
size of infarct and initial stroke severity were related to the 
development of ES. However, after the multivariate analysis 
these factors did not result statistically signiﬁ  cant.
We identiﬁ  ed hemorrhagic transformation as a risk factor 
for ES in ﬁ  rst-ever stroke patients. In all patients except one, 
the HT was cortical. The pathophysiology of seizures after 
stroke is not completely understood but several mechanisms 
are hypothesized: cellular biochemical dysfunction with 
membrane instability of injured cells; transient excitoxic 
neurotransmitter release, such as glutamate, secondary to 
hypoxia; free radical damage; alteration of energy metabo-
lism; transient depolarizations of the ischemic penumbra 
with a resulting electrical irritable tissue (Heuts-van Raak 
et al 1996; Herman 2002; Camilo and Goldstein 2004). The 
presence of HT, especially in cortical regions, where it is often 
associated with edema, could increase the excitability of the 
cortical ischemic penumbra tissue, which is already suffer-
ing. Being so, cortical HT could be hypothesized as a focus 
for seizure activity. The increased brain excitability in the 
presence of HT seems to be conﬁ  rmed by a recent study that 
has evidenced HT as an independent predictor of epilepticus 
status in acute ischemic stroke (Bateman et al 2007).
We did not ﬁ  nd an association between HT and antithrom-
botic therapy during acute stroke, being so, we hypothesized 
that the use of anticoagulant or antiaggregants is not relevant 
for the presence of ES.
The inﬂ  uence of post-stroke ES on functional outcome 
is controversial. In the present study, ES were not associated 
with an adverse outcome at discharge. However some stud-
ies have reported a higher disability/mortality in patients 
with post-stroke ES (Bladin et al 2000; Lamy et al 2003). In 
particular, in a prospective study the in-hospitality mortal-
ity rate was signiﬁ  cantly higher in ischemic stroke patients 
with ES than in those without ES (Arboix et al 2003). This 
association has not yet been conﬁ  rmed by other studies after 
adjusting for stroke severity (Reith et al 1997; Labovitz et al 
2001). Some authors have hypothesized that ES in ischemic 
stroke patients could worsen the patient outcome, because it 
causes additional metabolic stress in the suffering penumbral 
area (Reith et al 1997; Camilo and Goldstein 2004). However, 
there are no data available that ischemic damage could be 
increased by the hyperexcitability and the electric activity of 
cell membranes in necrotic tissue.
In conclusion, the result of our study show that about 
5% of patients with acute stroke developed ES within 7 days 
from stroke onset and that cortical hemorrhagic transforma-
tion of ischemic stroke is a risk factor for ES. Finally, ES 
does not seem to be an independent predictor for adverse 
outcome.Vascular Health and Risk Management 2008:4(3) 720
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